BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35276323)

  • 1. Revisiting immunological and clinical aspects of membranous nephropathy.
    Nieto-Gañán I; Iturrieta-Zuazo I; Rita C; Carrasco-Sayalero Á
    Clin Immunol; 2022 Apr; 237():108976. PubMed ID: 35276323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy.
    Wang J; Cui Z; Lu J; Probst C; Zhang YM; Wang X; Qu Z; Wang F; Meng LQ; Cheng XY; Liu G; Debiec H; Ronco P; Zhao MH
    Clin J Am Soc Nephrol; 2017 Oct; 12(10):1642-1651. PubMed ID: 28801527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China.
    Zhang D; Zou J; Zhang C; Zhang W; Lin F; Jiang G
    Med Sci Monit; 2018 Jul; 24():5076-5083. PubMed ID: 30032157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating antibodies against M-type phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in Chinese patients with membranous nephropathy.
    Tian C; Li L; Liu T; Qu X; Qiu Y
    Int Urol Nephrol; 2019 Aug; 51(8):1371-1377. PubMed ID: 31227982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of M
    Gong Z; Yuan S; Zhu X; Wang Y; Yu F; Yang D; Xu X; Liu H; Li J; Sun L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 45(6):693-700. PubMed ID: 32879127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membranous nephropathy: integrating basic science into improved clinical management.
    Cattran DC; Brenchley PE
    Kidney Int; 2017 Mar; 91(3):566-574. PubMed ID: 28065518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rare case of PLA2R- and THSD7A-positive idiopathic membranous nephropathy.
    Wanderley DC; Jones BD; Barbosa FAM; Araujo SA
    J Bras Nefrol; 2019 Oct; 42(2):254-258. PubMed ID: 31663595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical Significance of Thrombospondin Type 1 Domain-Containing 7A and Neural Epidermal Growth Factor-Like 1 Protein in M-Type Phospholipase A2 Receptor-Negative Membranous Nephropathy].
    Tang XL; DU YY; Yu J; Ye T; Zhu H; Chen YF; Li XH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Apr; 45(2):235-244. PubMed ID: 37157070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain.
    L'Imperio V; Pieruzzi F; Sinico RA; Nebuloni M; Granata A; Smith A; Radice A; Pagni F
    J Nephrol; 2018 Aug; 31(4):543-550. PubMed ID: 29626294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy.
    Kumar V; Ramachandran R; Kumar A; Nada R; Suri D; Gupta A; Kohli HS; Gupta KL; Jha V
    Nephrology (Carlton); 2015 Aug; 20(8):572-5. PubMed ID: 26194981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on clinical significance of use of THSD7A in diagnosing idiopathic membranous nephropathy: a systematic review and meta-analysis of THSD7A in IMN.
    Ren S; Wu C; Zhang Y; Wang AY; Li G; Wang L; Hong D
    Ren Fail; 2018 Nov; 40(1):306-313. PubMed ID: 29623759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of the determination of antibodies to thrombospondin type 1 containing domain 7A (THSD7A) in membranous nephropathy].
    Kakhsurueva PA; Kamyshova ES; Bobkova IN; Stavrovskaya EV; Rudenko TE; Andreeva EY
    Ter Arkh; 2023 Aug; 95(6):462-467. PubMed ID: 38158964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.
    Radice A; Pieruzzi F; Trezzi B; Ghiggeri G; Napodano P; D'Amico M; Stellato T; Brugnano R; Ravera F; Rolla D; Pesce G; Giovenzana ME; Londrino F; Cantaluppi V; Pregnolato F; Volpi A; Rombolà G; Moroni G; Ortisi G; Sinico RA
    J Nephrol; 2018 Apr; 31(2):271-278. PubMed ID: 29081027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Enhanced Granular Expression of Thrombospondin Type-1 Domain-Containing 7A in the Glomeruli of Japanese Patients with Idiopathic Membranous Nephropathy.
    Iwakura T; Ohashi N; Kato A; Baba S; Yasuda H
    PLoS One; 2015; 10(9):e0138841. PubMed ID: 26393352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic determinants of the development and course of membranous nephropathy.
    Kamyshova ES; Bobkova IN; Gorelova IA; Каkhsurueva PA; Filatova EE
    Ter Arkh; 2018 Jun; 90(6):105-111. PubMed ID: 30701913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Glomerular Mannose-Binding Lectin Deposition on the Prognosis of Idiopathic Membranous Nephropathy.
    Zhang Y; Liu Y; Liang L; Liu L; Tang X; Tang L; Chen P; Chen J; Wang Z; Cao W; Chen Q; Zhao N; Xu D
    Kidney Blood Press Res; 2020; 45(5):713-726. PubMed ID: 32894840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membranous nephropathy associated with thrombospondin type-1 domain-containing 7A (THSD7A) in an adult woman with eosinophilia.
    Shirai S; Akiyama S; Kamijo-Ikemori A; Suzuki T; Ichikawa D; Koike J; Kimura K; Shibagaki Y
    CEN Case Rep; 2020 Feb; 9(1):65-73. PubMed ID: 31705303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-PLA2R and anti-THSD7A as Diagnostic Serological Markers of Idiopathic Membranous Nephropathy: A Single Centre Study.
    Fouad MA; Mahedy AW; Mansour AE; Fouad NA
    Egypt J Immunol; 2020 Jun; 27(2):1-9. PubMed ID: 33548972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocyte Antigen Staining to Identify Distinct Phenotypes and Outcomes in Membranous Nephropathy: A Retrospective Multicenter Cohort Study.
    Hanset N; Aydin S; Demoulin N; Cosyns JP; Castanares-Zapatero D; Crott R; Cambier JF; Pochet JM; Gillerot G; Reginster F; Houssiau F; Debiec H; Ronco P; Jadoul M; Morelle J;
    Am J Kidney Dis; 2020 Nov; 76(5):624-635. PubMed ID: 32668319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Features of phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in malignancy-associated membranous nephropathy.
    Zhang C; Zhang M; Chen D; Ren Q; Xu W; Zeng C; Qin W; Liu Z
    J Clin Pathol; 2019 Oct; 72(10):705-711. PubMed ID: 31243053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.